72 related articles for article (PubMed ID: 36040381)
1. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
Tuluhong D; Gao H; Li X; Wang L; Zhu Y; Xu C; Wang J; Li H; Li Q; Wang S
Exp Cell Res; 2023 Dec; 433(1):113805. PubMed ID: 37839786
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CHCHD2P9 and ZNF204P in breast cancer: exploring their expression patterns and associations with malignancy-related genes.
Rastegari M; Sazegar H; Doosti A
Mol Biol Rep; 2024 Jun; 51(1):707. PubMed ID: 38824255
[TBL] [Abstract][Full Text] [Related]
3. Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer.
Xie W; Xu H; Cheng Y; Lin X; Zeng J; Sun Y
Technol Cancer Res Treat; 2024; 23():15330338241254219. PubMed ID: 38780484
[TBL] [Abstract][Full Text] [Related]
4. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
Chen Q; Ouyang L; Liu Q
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
Gong X; Gong Y; Wu G; Ke H
Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognosis analysis of GINS subunits in human breast cancer.
Li H; Cao Y; Ma J; Luo L; Ma B
Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
[TBL] [Abstract][Full Text] [Related]
7. Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer.
Li Y; Yang X; Geng C; Liu Y; Tang T; Zhang L; Liu F; Zhang M; Hao J; Ma L
Front Immunol; 2024; 15():1390261. PubMed ID: 38726001
[TBL] [Abstract][Full Text] [Related]
8. The Valuable Role of ARMC1 in Invasive Breast Cancer as a Novel Biomarker.
Gan Y; Zhong F; Wang H; Li L
Biomed Res Int; 2022; 2022():1740295. PubMed ID: 35378785
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of
Tang X; Wu J; Chen Y; Wang D; Wang T; Weng Y; Zhu Z; Peng R; Wang Y; Yan F
Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38527246
[No Abstract] [Full Text] [Related]
10.
Zhou Y; Xue W; Meng X; Bhandari A; Zeng H; Kc R; Hirachan S; Xia E
Breast Cancer (Dove Med Press); 2024; 16():71-89. PubMed ID: 38476642
[TBL] [Abstract][Full Text] [Related]
11. Immune response pathways enriched in breast cancer samples with brain metastasis.
Wang P; Sun Z; Zhang Z; Yin Q
Gland Surg; 2021 Dec; 10(12):3334-3341. PubMed ID: 35070893
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
[TBL] [Abstract][Full Text] [Related]
13. Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis.
Zeng Y; Fan R
Sci Rep; 2022 Sep; 12(1):16153. PubMed ID: 36167975
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional analysis of lactic acid metabolism-related differentially expressed genes in hepatocellular carcinoma.
Li H; Qian F; Bao S
Front Genet; 2024; 15():1390882. PubMed ID: 38689649
[No Abstract] [Full Text] [Related]
15. Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization.
Lin Y; Wang S; Yang Q
Discov Oncol; 2024 Apr; 15(1):117. PubMed ID: 38609711
[TBL] [Abstract][Full Text] [Related]
16. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
17. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
Fu H; Li K; Wang S; Li Y
Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
[TBL] [Abstract][Full Text] [Related]
18. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
[TBL] [Abstract][Full Text] [Related]
19. Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases.
Cai KT; Liu AG; Wang ZF; Jiang HW; Zeng JJ; He RQ; Ma J; Chen G; Zhong JC
Mol Med Rep; 2019 Feb; 19(2):1168-1184. PubMed ID: 30569120
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
